Notice Regarding NTK’s Filing of Appeal in Damages Claim Against Daiichi Sankyo
Filed with TSE · · 2 pages · English
Watch Daiichi Sankyo's latest callDaiichi Sankyo (Tokyo:4568) Q1 2026 Earnings Call · Replay · Jul 31Read the transcript of Daiichi Sankyo (Tokyo:4568) Q1 2026 Earnings CallCompany name: DAIICHI SANKYO COMPANY, LIMITED Representative: Hiroyuki Okuzawa, Representative Director, President and CEO (Code no.: 4568, Prime Market, Tokyo Stock Exchange) Please address inquiries to Ari Fujishiro, Corporate Officer, Head of Investor Relations and Shareholder Relations Department Telephone: for media +81-3-6225-1126 for stock market participants +81-3-6225-1125 Notice Regardin
Daiichi Sankyo Company, Limited on 6ix
Earlier from Daiichi Sankyo
- Ifinatamab Deruxtecan Biologics License Application for Certain Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer Voluntarily Withdrawn
- Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in DESTINY-Lung04 Phase III trial
- Daiichi Sankyo Receives Favorable Judgment in Damage Claim Filed by NTK
- Enhertu® Plus Pertuzumab Approved in the EU as First New Regimen in More than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
Later from Daiichi Sankyo
- Daiichi Sankyo and AstraZeneca Enter into Clinical Trial Collaboration with Summit Therapeutics to Evaluate Datroway® in Combination with Ivonescimab Across Multiple Tumor Types
- Consolidated Financial Results for the First Six Months of the Year Ending March 31,2027(Fiscal 2026)
- FY2026 Q2 Financial Results Presentation
- Reference Data (Consolidated Financial Results for Q2 FY2026)
- Daiichi Sankyo Reports Second Quarter Fiscal Year 2026 Financial Results
Follow Daiichi Sankyo into a list and get an email when it puts out news.
Follow Daiichi Sankyo